mTOR基因多态性与小儿癫癎易感性的相关性

乐鑫; 赵培伟; 刘智胜; 吴革菲; 涂飞; 胡家胜; 何学莲

doi:10.7499/j.issn.1008-8830.2015.06.005

PDF(513 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (6) : 560-564. DOI: 10.7499/j.issn.1008-8830.2015.06.005

神经系统疾病专题

mTOR基因多态性与小儿癫癎易感性的相关性

乐鑫¹, 赵培伟¹, 刘智胜², 吴革菲², 涂飞¹, 胡家胜², 何学莲¹

作者信息 +

Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy

YUE Xin¹, ZHAO Pei-Wei¹, LIU Zhi-Sheng², WU Ge-Fei², TU Fei¹, HU Jia-Sheng², HE Xue-Lian¹

Author information +

文章历史 +

摘要

目的探讨哺乳动物雷帕霉素靶蛋白(mTOR)基因两个SNP 位点rs2295080 和rs2536 的多态性与小儿癫癎易感性的关系。方法采用病例对照研究, 选取480 例癫癎患儿(包括116 例难治性癫癎)以及503 例健康儿童作为研究对象。利用PCR-RFLP 方法进行两个SNP 位点的多态性检测, 比较两组儿童基因型及等位基因的分布频率。结果癫癎组SNP 位点rs2295080 的基因型(TT、TG、GG)频率和等位基因频率与健康对照组比较差异均无统计学意义(P>0.05);SNP 位点rs2536 的基因型(AA、AG、GG)频率两组比较差异亦无统计学意义(P>0.05), 但癫癎组的等位基因G 频率显著高于健康对照组(OR=1.344, P=0.042, 95%CI：1.010~1.789)。结论 mTOR 基因SNP 位点rs2536 与癫癎的易感性可能相关。

Abstract

Objective To study the association between two single nucleotide polymorphisms (SNP), rs2295080 and rs2536, in mammalian target of rapamycin (mTOR) gene and the susceptibility to pediatric epilepsy. Methods A case-control study was performed on 480 children with epilepsy (116 cases of refractory epilepsy) and 503 healthy children. SNP rs2295080 and rs2536 in the mTOR gene were detected by polymerase chain reaction restriction and fragment length polymorphisms (PCR-RFLP). Genotype and allele frequencies of SNP rs2295080 and rs2536 were compared between the children with epilepsy and healthy controls. Results There were no significant differences in the genotype and allele frequencies of SNP rs2295080 between the children with epilepsy and healthy controls. There were no significant differences in the genotype frequencies of SNP rs2536 between the two groups either, but the frequency of G allele of SNP rs2536 was higher in children with epilepsy than that in healthy controls (P=0.042, OR=1.344, 95%CI:1.010-1.789). Conclusions SNP rs2536 of mTOR gene may be associated with the risk of pediatric epilepsy.

导出引用

乐鑫, 赵培伟, 刘智胜, 吴革菲, 涂飞, 胡家胜, 何学莲. mTOR基因多态性与小儿癫癎易感性的相关性[J]. 中国当代儿科杂志. 2015, 17(6): 560-564 https://doi.org/10.7499/j.issn.1008-8830.2015.06.005

YUE Xin, ZHAO Pei-Wei, LIU Zhi-Sheng, WU Ge-Fei, TU Fei, HU Jia-Sheng, HE Xue-Lian. Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(6): 560-564 https://doi.org/10.7499/j.issn.1008-8830.2015.06.005

参考文献

[1] Lipton JO, Sahin M. The neurology of mTOR [J]. Neuron, 2014, 84(2):275-291.
[2] Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy [J]. J Neurosci, 2009, 29(21):6964-6972.
[3] Shao JB, Li Y, Zhao PW, et al. Association of mTOR polymorphisms with cancer risk and clinical outcomes:a metaanalysis[J]. PloS one, 2014, 9(5):e97085.
[4] Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) [J]. Epilepsia, 2005, 46(4):470-472.
[5] Kwiatkowski DJ. Tuberous sclerosis:from tubers to mTOR [J]. Ann Hum Genet, 2003, 67(Pt1):87-96.
[6] Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSCmTOR pathway in human disease [J]. Nat Genet, 2005, 37(1):19-24.
[7] Crino PB. mTOR:A pathogenic signaling pathway in developmental brain malformations [J]. Trends Mol Med, 2011, 17(12):734-742.
[8] Galanopoulou AS, Gorter JA, Cepeda C. Finding a better drug for epilepsy:The mTOR pathway as an antiepileptogenic target[J]. Epilepsia, 2012, 53(7):1119-1130.
[9] Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly [J]. Nat Genet, 2012, 44(8):941-945.
[10] Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations [J]. Neuron, 2012, 74(1):41-48.
[11] Epi4K Consortium; Epilepsy Phenome/Genome Project (Allen AS, Berkovic SF, Cossette P, et al). De novo mutations in epileptic encephalopathies [J]. Nature, 2013, 501(7466):217- 221.
[12] 林堃, 林元相, 康德智. mTOR 信号通路与癫癎[J]. 国际神经病学神经外科学杂志, 2012, 39(2):168-172.
[13] Cao Q, Ju X, Li P, et al. A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk [J]. PLoS One, 2012, 7(11):e50302.
[14] Li Q, Gu C, Zhu Y, et al. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population[J]. PLoS One, 2013, 8(8):e71968.
[15] Huang L, Huang J, Wu P, et al. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population [J]. Leuk Lymphoma, 2012, 53(5):947- 951.